Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01852656 · ClinicalTrials.gov registry record · NA
Effectiveness of Influenza Vaccine Reminder Systems
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 12,255
- Enrollment target
NCT01852656: Completed NA study, sponsored by Kaiser Permanente.
NCT01852656 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 12,255 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (773% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01852656, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 12,255 participants
- Enrollment target
Study Summary
Influenza disease causes significant morbidity and mortality in the Unites States each year. Although influenza can cause morbidity in otherwise healthy individuals, adults with chronic lung disease have significantly increased rates of hospitalization from influenza-related illnesses compared to healthy adults. Influenza vaccination is the primary means of preventing influenza disease. Annual influenza vaccination is recommended for all individuals 6 months of age and older in the United States. Influenza vaccination rates are sub-optimal, however. Patient reminder/recall has been shown, in multiple studies across a variety of age groups and health conditions, to increase immunization rates. However, the effectiveness and cost-effectiveness of different types of reminder/recall has not been well-studied, particularly in adults. In the fall of 2012, the Population and Prevention Services (PPS) Department at Kaiser Permanente Colorado (KPCO) is using 3 different reminder strategies for influenza vaccination among adults with asthma and chronic obstructive pulmonary disease (COPD). The objective of this study is to provide a rigorous evaluation of which strategy is more effective and more cost-effective, to promote influenza vaccination.
Primary Outcome
The 2012-2013 influenza season, defined as October to April.
Interventions
- BEHAVIORAL Postcard and IVR Reminder Group
- BEHAVIORAL Postcard Only Reminder Group
- BEHAVIORAL IVR Only Reminder Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,255 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-04 |
| Phase | NA |
What the finished NCT01852656 record still lists
NCT01852656 is an interventional study that assigns participants to a tested intervention. Its 12,255 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (773% higher).
The record links to 0 conditions, and to 3 interventions - of which Postcard and IVR Reminder Group is the first listed.
NCT01852656 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01852656 about?
NCT01852656 is a clinical study titled "Effectiveness of Influenza Vaccine Reminder Systems". Influenza disease causes significant morbidity and mortality in the Unites States each year. Although influenza can cause morbidity in otherwise healthy individuals, adults with chronic lung disease have significantly increased rates of hospitalization from influenza-related illnesses compared to he...
What is the current status of trial NCT01852656?
This trial is currently completed. It is a NA study. The enrollment target is 12,255 participants. The study started on 2012-09. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01852656?
The interventions under investigation include: Postcard and IVR Reminder Group (BEHAVIORAL), Postcard Only Reminder Group (BEHAVIORAL), IVR Only Reminder Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT01852656?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01852656's enrollment target sits among peer trials
12,255 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04888832 · 12,500 participants · NA
The Effect of Work Requirements in SNAP in Virginia
- NCT05452941 · 12,500 participants
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
- NCT07069556 · 12,500 participants
ColoSense Post-Approval Study
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia